Correlation of MR Imaging and MR Spectroscopy Findings with Cognitive Impairment in Mucopolysaccharidosis II

References

1. ↵
   Neufeld E, Musner J. The mucopolysaccharidoses. In: Scriver C, Beudet A, Sly W, Valle D, eds. The Metabolic and Molecular Bases on Inherited Disease. 8th ed. New York: McGraw-Hill;2001 :3421–52
2. ↵
   Meikle PJ, Hopwood JJ, Clague AE, et al. Prevalence of lysosomal storage disorders. JAMA 1999;281:249–54

   CrossRefPubMedWeb of Science
3. ↵
   Muenzer J, Wraith JE, Beck M, et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 2006;8:465–73

   CrossRefPubMedWeb of Science
4. ↵
   Lee C, Dineen TE, Brack M, et al. The mucopolysaccharidoses: characterization by cranial MR imaging. AJNR Am J Neuroradiol 1993;14:1285–92

   Abstract/FREE Full Text
5. ↵
   Murata R, Nakajima S, Tanaka A, et al. MR imaging of the brain in patients with mucopolysaccharidosis. AJNR Am J Neuroradiol 1989;10:1165–70

   Abstract/FREE Full Text
6. Shimoda-Matsubayashi S, Kuru Y, Sumie H, et al. MRI findings in the mild type of mucopolysaccharidosis II (Hunter's syndrome). Neuroradiology 1990;32:328–30

   CrossRefPubMed
7. Parsons VJ, Hughes DG, Wraith JE. Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter's syndrome (mucopolysaccharidoses type II). Clin Radiol 1996;51:719–23

   CrossRefPubMed
8. ↵
   Seto T, Kono K, Morimoto K, et al. Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol 2001;50:79–92

   CrossRefPubMed
9. ↵
   Gabrielli O, Polonara G, Regnicolo L, et al. Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am J Med Genet A 2004;125:224–31

   PubMed
10. ↵
    Matheus MG, Castillo M, Smith JK, et al. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 2004;46:666–72

    CrossRefPubMedWeb of Science
11. ↵
    Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1–15

    PubMed
12. Bianchi MC, Tosetti M, Battini R, et al. Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance. AJNR Am J Neuroradiol 2003;24:1958–66

    Abstract/FREE Full Text
13. ↵
    Hunter JV, Wang ZJ. MR spectroscopy in pediatric neuroradiology. Magn Reson Imaging Clin N Am 2001;9:165–89, ix

    PubMed
14. ↵
    Takahashi Y, Sukegawa K, Aoki M, et al. Evaluation of accumulated mucopolysaccharides in the brain of patients with mucopolysaccharidoses by (1)H-magnetic resonance spectroscopy before and after bone marrow transplantation. Pediatr Res 2001;49:349–55

    CrossRefPubMed
15. ↵
    Siegel DA, Walkley SU. Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside. J Neurochem 1994;62:1852–62

    PubMedWeb of Science
16. ↵
    Hochuli M, Wuthrich K, Steinmann B. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses. NMR Biomed 2003;16:224–36

    CrossRefPubMed
17. ↵
    Vougioukas VI, Berlis A, Kopp MV, et al. Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg 2001;35:35–38

    CrossRefPubMed
18. ↵
    Robertson SP, Klug GL, Rogers JG. Cerebrospinal fluid shunts in the management of behavioural problems in Sanfilippo syndrome (MPS III). Eur J Pediatr 1998;157:653–55

    CrossRefPubMed
19. ↵
    Barone R, Parano E, Trifiletti RR, et al. White matter changes mimicking a leukodystrophy in a patient with mucopolysaccharidosis: characterization by MRI. J Neurol Sci 2002;195:171–75

    CrossRefPubMedWeb of Science
20. Mancini GM, van Diggelen OP, Huijmans JG, et al. Pitfalls in the diagnosis of multiple sulfatase deficiency. Neuropediatrics 2001;32:38–40

    CrossRefPubMedWeb of Science
21. Ben-Zeev B, Gross V, Kushnir T, et al. Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients. J Child Neurol 2001;16:93–99

    Abstract/FREE Full Text
22. ↵
    Kurihara M, Kumagai K, Goto K, et al. Severe type Hunter's syndrome. Polysomnographic and neuropathological study. Neuropediatrics 1992;23:248–56

    PubMed
23. ↵
    Meier C, Wismann U, Herschkowitz N, et al. Morphological observations in the nervous system of prenatal mucopolysaccharidosis II (M. Hunter). Acta Neuropathol (Berl)1979;48:139–43

    CrossRefPubMed
24. ↵
    Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289–98

    CrossRefPubMedWeb of Science
25. ↵
    Katz-Brull R, Lenkinski RE, Du Pasquier RA, et al. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology 2004;63:897–900

    Abstract/FREE Full Text
26. Vrenken H, Barkhof F, Uitdehaag BM, et al. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med 2005;53:256–66

    CrossRefPubMedWeb of Science
27. ↵
    Ashwal S, Holshouser B, Tong K, et al. Proton spectroscopy detected myoinositol in children with traumatic brain injury. Pediatr Res 2004;56:630–38

    CrossRefPubMed
28. Mucke L, Oldstone MB, Morris JC, et al. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol 1991;3:465–74

    PubMedWeb of Science
29. Kim JP, Lentz MR, Westmoreland SV, et al. Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. AJNR Am J Neuroradiol 2005;26:752–59

    Abstract/FREE Full Text
30. ↵
    Walkley SU. Cellular pathology of lysosomal storage disorders. Brain Pathol 1998;8:175–93

    PubMedWeb of Science
31. ↵
    Walkley SU, Haskins ME, Shull RM. Alterations in neuron morphology in mucopolysaccharidosis type I. A Golgi study. Acta Neuropathol (Berl)1988;75:611–20

    CrossRefPubMed
32. ↵
    Inglese M, Nusbaum AO, Pastores GM, et al. MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis. AJNR Am J Neuroradiol 2005;26:2037–42

    Abstract/FREE Full Text
33. ↵
    Yamasue H, Fukui T, Fukuda R, et al. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. Neuroreport 2002;13:2133–37

    CrossRefPubMedWeb of Science
34. ↵
    Saraf-Lavi E, Bowen BC, Pattany PM, et al. Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels. AJNR Am J Neuroradiol 2003;24:946–51

    Abstract/FREE Full Text